Bill would ease barriers to joining clinical trials

What does this do?

This bill changes federal rules so drug and device companies can legally pay participants' medical costs, travel, meals, and provide free digital health tools during clinical trials. It also excludes up to $2,000 per year in trial payments from a participant's taxable income. Federal grants would fund outreach and education in multiple languages to recruit more diverse participants and investigators.

Who does it affect?

People from rural communities, tribal areas, and lower-income backgrounds are specifically named as groups this bill aims to reach. Drug, device, and vaccine companies, as well as clinical trial investigators, are also affected.

Why does it matter?

Without this bill, out-of-pocket costs and lack of support can make it hard for many people to join clinical trials. These changes shift who can realistically participate and how companies are allowed to support them under federal law.

What does it cost, and who pays?

• Federal grants authorized
• Amount unspecified